| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
UNITEDHEALTH GROUP INCORPORATED (Delaware)$425.28
-3.72 (-0.87%)
Market Cap
276.23 B
EPS
13.26
P/E Ratio
23.07 $
Value Trade
2.61 B
SEC Financials
Q1 2026Dilution Risk
Revenue
111.72 B
Operating CF
8.91 B
Total Assets
312.64 B
Total Liabilities
207.32 B
Equity
103.89 B
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
31.23 B
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 5, 2026
Overview
Volume
1.65 M
52 Week Range
234.60 - 595.63
% held by Insiders
0.24 %
% held by Institutions
85.41 %
Enterprise Value
366.82 B
Total Shares
907.66 M
Short %
1.91 %
Float Shares
847.75 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in UNH
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
UNH Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2027-01-15 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2027-01-15 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2027-01-15 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-UNH
Jul 29, 2026▼ -0.9%today
UnitedHealth Group Partners with UT Health Sciences to Expand Health Hubs to More Communities Across Tennessee
UnitedHealth Group has announced a $4 million commitment to expand the University of Tennessee Health Sciences' health hub model across Tennessee. This initiative will increase the number of health hubs from five to thirteen, enhancing access to preventive care and chronic condition support for local communities. The expansion aims to improve health resources available to Tennesseans.
Read more →-UNH
Jul 16, 2026UnitedHealth Group Reports Second Quarter 2026 Results
UnitedHealth Group reported its second quarter 2026 results, showcasing progress in operational simplification and enhancing patient care. The company has raised its guidance for the full year 2026, reflecting a positive outlook. CEO Stephen Hemsley emphasized the commitment to affordability and improved healthcare experiences through modern technology.
Read more →-UNH
Jul 9, 2026UnitedHealthcare Launches New Spending Account Benefit, Putting More Choice in the Hands of Consumers
UnitedHealthcare has launched a new Lifestyle Spending Account (LSA) to provide employers with a flexible benefit that supports employees' health and well-being. This account allows employees to personalize their health experiences and shop for products and services that complement existing benefits. The LSA is integrated with the UHC Store for enhanced accessibility.
Read more →-UNH
Jun 30, 2026UnitedHealthcare Community Plan of Nebraska Invests $385,000 to Expand Programs to Support Older Adults, Caregivers and People with Disabilities
UnitedHealthcare Community Plan of Nebraska has announced a $385,000 investment aimed at expanding programs to support older adults, caregivers, and individuals with disabilities. This initiative reflects the company's commitment to enhancing community health services. The funding will likely facilitate improved access to resources for these populations.
Read more →-UNH
Jun 11, 2026UnitedHealth Group Announces Earnings Release Date
UnitedHealth Group has announced the date for its upcoming earnings release. The announcement is part of the company's regular financial reporting schedule, which is closely monitored by investors and analysts. Further details regarding the earnings report will likely be provided as the date approaches.
Read more →-UNH
Jun 3, 2026UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
UnitedHealth Group has provided an update regarding its annual shareholder meeting and board actions. The details shared are limited, focusing on procedural aspects rather than specific outcomes or changes. This announcement does not indicate any significant developments or shifts in strategy at this time.
Read more →-UNH
Apr 21, 2026▲ +7%on this news
UnitedHealth Group Reports First Quarter 2026 Results
UnitedHealth Group reported strong first quarter results for 2026, with revenues of $111.7 billion and adjusted net earnings per share of $7.23. The company is focusing on simplifying healthcare and enhancing consumer experiences, supported by significant investments in technology. However, it faced challenges such as increased operating costs and a decline in Medicare Advantage enrollment. The company also announced plans to acquire Alegeus Technologies and repurchase $2 billion of its common stock.
Read more →-UNH
Oct 28, 2025Document UnitedHealth Group Reports Third Quarter 2025 Results and Raises Full Year 2025 Earnings Outlook Third Quarter 2025 Revenues of $113.2 Billion Grew 12% Year-Over-Year Third Quarter Earnings of $2.59 Per Share, A
UnitedHealth Group reported robust third quarter 2025 results with revenues increasing by 12% year-over-year to $113.2 billion and earnings per share adjusted to $2.92. The company raised its full year earnings forecast, now expecting adjusted earnings of at least $16.25 per share. Despite these growth indicators, earnings from operations saw a significant decline of 50% compared to the previous year, and the net margin decreased to 2.1%. Challenges were noted in operating margins, attributed to elevated medical costs and ongoing Medicare funding impacts.
Read more →-UNH
Jul 31, 2025▼ -6.2%on this news
UnitedHealth Group Announces Changes to Leadership Team (
UnitedHealth Group has announced the appointment of Wayne S. DeVeydt as CFO, effective September 2, 2025, replacing John F. Rex who will take on a strategic advisory role. DeVeydt, who has a significant background in healthcare finance, previously held leadership positions at Bain Capital and Surgery Partners. The transition is anticipated to enhance the company's vision and operational efficiency, with Rex remaining involved in advisory capacities.
Read more →-UNH
Jul 29, 2025▼ -7.5%on this newsshared move
Document UnitedHealth Group Re-Establishes Full Year Outlook and Reports Second Quarter 2025 Results Full Year 2025 Revenue Outlook of $445.5 Billion to $448.0 Billion Full Year 2025 Earnings Outlook of at least $14.65 P
UnitedHealth Group has revised its 2025 outlook, now projecting revenues between $445.5 billion and $448.0 billion and earnings per share of at least $14.65. In its second quarter report, the company announced earnings of $3.74 per share, with adjusted earnings at $4.08. Despite the positive growth indicators, the company also acknowledged rising medical costs contributing to an increased medical care ratio, which has posed challenges to its financial performance. Overall, the company expresses confidence in regaining earnings growth potential by 2026.
Read more →-UNH
May 13, 2025▼ -17.8%on this news
Document PRESS RELEASE UnitedHealth Group Announces Leadership Transition Stephen J. Hemsley named Chief Executive Officer Company suspends 2025 outlook as medical expenditures expected to be higher than anticipated Comp
UnitedHealth Group has announced the appointment of Stephen J. Hemsley as CEO following Andrew Witty's resignation for personal reasons. The company, which expects to return to growth in 2026, has suspended its 2025 outlook due to rising medical expenditures and unexpectedly high costs associated with new Medicare Advantage beneficiaries. This leadership transition occurs during a time of accelerated care activity and an expansion of benefit offerings. Hemsley, who previously served as CEO, returns to lead the company amidst these challenges.
Read more →-UNH
Apr 17, 2025▼ -22.4%on this news
Document UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings
UnitedHealth Group reported its first quarter 2025 results, indicating revenues of $109.6 billion, a $9.8 billion increase year-over-year. The company revises its full-year earnings guidance, now setting earnings per share expectations between $24.65 and $25.15, amid challenges in Medicare Advantage performance and unexpected changes in Optum Health member profiles. Despite these setbacks, the company's president emphasized a commitment to navigate challenges and return to long-term growth targets. The number of consumers served has increased significantly, adding to optimism about future growth.
Read more →-UNH
Jan 16, 2025▼ -6%on this news
Document UnitedHealth Group Reports 2024 Results Revenues of $400.3 Billion Grew 8% Year-Over-Year Domestic Consumers Served by UnitedHealthcare Grew 2.1 Million Value-Based Care Patients Served by Optum Grew 600,000 Cas
UnitedHealth Group reported strong financial results for 2024, with revenues of $400.3 billion, an 8% increase from the previous year. The company also noted the addition of 2.1 million domestic consumers and 600,000 new value-based care patients through Optum. Despite these gains, the medical care ratio increased, highlighting some financial pressures, and Optum Insight faced challenges due to a revenue decline from a past cyberattack. Looking ahead, the company provided an optimistic forecast for 2025.
Read more →-UNH
Dec 4, 2024Document UnitedHealth Group Statement on Today's Events (
UnitedHealth Group expressed its deep sorrow over the passing of CEO Brian Thompson in a recent statement. His loss is felt profoundly by colleagues and friends within the organization. The company is collaborating with the New York Police Department as they navigate this challenging period. UnitedHealth Group reassures that it remains committed to supporting Thompson's family and those affected by his passing.
Read more →-UNH
Oct 15, 2024▼ -8.1%on this news
Document UnitedHealth Group Reports Third Quarter 2024 Results Revenues of $100.8 Billion Grew $8.5 Billion Year Over Year Consumers Served by UnitedHealthcare's Commercial Domestic Offerings Grew 2.4 Million Year to Dat
UnitedHealth Group reported strong third quarter results for 2024, with revenues of $100.8 billion, reflecting a growth of $8.5 billion year-over-year. The number of consumers served by UnitedHealthcare's domestic offerings increased by 2.4 million. Adjusted earnings per share were reported at $7.15, while net earnings outlook accounted for disruptions due to cyberattacks. Despite operational growth, the company faced increased medical care costs, with the ratio rising to 85.2% compared to the previous year.
Read more →-UNH
Jul 16, 2024▲ +6.5%on this news
Document UnitedHealth Group Reports Second Quarter 2024 Results Revenues of $98.9 Billion Grew Nearly $6 Billion Year Over Year, Led by Optum Consumers Served by UnitedHealthcare's Commercial Domestic Offerings Grew 2.3
UnitedHealth Group reported strong second quarter results for 2024, posting revenues of $98.9 billion, up nearly $6 billion year over year. The company's growth was led by Optum and an increase in consumers served by UnitedHealthcare. However, earnings were affected by a $0.92 per share loss due to a recent cyberattack and the classification of South American operations as held for sale. Despite these challenges, the operational cash flow remained robust at $6.7 billion.
Read more →-UNH
Apr 16, 2024▲ +5.2%on this news
Document UnitedHealth Group Reports First Quarter 2024 Results Revenues of $99.8 Billion Grew Nearly $8 Billion Year Over Year Earnings Reflect $0.74 per Share of Impacts from Change Healthcare Cyberattack $0.49 to Suppo
UnitedHealth Group reported strong first quarter 2024 results with revenues of $99.8 billion, reflecting an $8 billion increase from the previous year. The performance was impacted by a cyberattack on Change Healthcare, resulting in an estimated loss of $0.74 per share, with projections of total impacts for the year ranging from $1.15 to $1.35 per share. The company maintained its adjusted earnings outlook while incurring costs for restoration and support to affected providers. Additionally, a net loss was reported primarily due to currency effects from the Brazil operations sale.
Read more →-UNH
Jan 12, 2024Document UnitedHealth Group Reports 2023 Results Revenues of $371.6 Billion Grew 15% Year-Over-Year Earnings from Operations Grew 14% Cash Flows from Operations were $29.1 Billion or 1.3x Net Income Full Year and Fourth
UnitedHealth Group reported strong financial results for 2023, with revenues of $371.6 billion and earnings from operations growing by 14%. The company emphasized growth in both its Optum and UnitedHealthcare segments, reflecting increased service provision and innovative offerings. However, it noted a decline in individuals served by state-based community offerings and a rise in medical care ratios, indicating potential cost pressures. The firm remains aligned with its performance objectives for 2024, factoring in a pending sale impacting net earnings.
Read more →-UNH
Nov 3, 2023Document Charlie Baker Joins UnitedHealth Group's Board of Directors (
UnitedHealth Group has appointed Charlie Baker, former Massachusetts governor and healthcare executive, to its Board of Directors effective immediately. Baker, who has a significant background in health care leadership, is expected to contribute positively to the company's mission to enhance healthcare outcomes. With a record of management in healthcare and government, his expertise aligns with UnitedHealth Group's objectives. The chairman expressed confidence in Baker's ability to help improve the healthcare system for all stakeholders.
Read more →-UNH
Oct 13, 2023Document UnitedHealth Group Reports Third Quarter 2023 Results Revenues of $92.4 Billion Grew 14% Year-Over-Year Earnings from Operations Grew 14% Cash Flows from Operations were $6.9 Billion Earnings were $6.24 Per Shar
UnitedHealth Group reported strong financial results for the third quarter of 2023, with revenues increasing by 14% year-over-year to $92.4 billion and earnings from operations also rising by 14% to $8.5 billion. The company's growth was driven by an increase in the number of people served through its Optum and UnitedHealthcare divisions. Net earnings outlook for the full year 2023 has been revised upwards, indicating a strong confidence in future performance. Cash flows from operations were robust, reaching $6.9 billion, further reflecting the company's solid financial health.
Read more →-UNH
Jul 14, 2023▲ +7.2%on this news
Document UnitedHealth Group Reports Second Quarter 2023 Results Revenues of $92.9 Billion Grew 16% Year-Over-Year Earnings from Operations Grew 13% Cash Flows from Operations were $11.0 Billion Earnings were $5.82 Per Sh
UnitedHealth Group reported impressive second-quarter results for 2023, with revenues reaching $92.9 billion, marking a 16% increase year-over-year. The growth was well-distributed across its businesses, with earnings from operations also rising by 13%. Cash flows from operations stood at $11 billion, reflecting the company's strong financial health. The company also adjusted its full-year earnings outlook upwards based on its performance in the first half of the year.
Read more →-UNH
Apr 14, 2023Document UnitedHealth Group Reports First Quarter 2023 Results Revenues of $91.9 Billion, Grew 15% Year-Over-Year Earnings from Operations Grew 16% Cash Flows from Operations were $16.3 Billion Adjusted Cash Flows from O
UnitedHealth Group reported first quarter 2023 results showing robust growth, with revenues of $91.9 billion, a 15% increase from the previous year. Earnings from operations also saw a significant rise, driven by strong performances from both Optum and UnitedHealthcare. The company has raised its earnings outlook for the year, reflecting confidence in its ongoing initiatives and market position. However, there was a slight increase in the medical care and operating cost ratios, indicating some pressure on profit margins. Overall, the results signal a strong performance and a positive trajectory for UnitedHealth Group in 2023.
Read more →-UNH
Jan 13, 2023Document UnitedHealth Group Reports 2022 Results Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Cash Flows from Operations were $26.2 Billion or 1.3x Net I
UnitedHealth Group reported robust financial results for 2022, with revenues increasing 13% to $324.2 billion, bolstered by strong performances in its Optum and UnitedHealthcare segments. The company achieved a cash flow from operations of $26.2 billion, illustrating solid operational efficiency. Looking ahead, UnitedHealth has set substantial growth targets for 2023, including revenues forecasted to reach between $357 billion and $360 billion. Net earnings per share are also projected to increase, indicating sustained confidence in business expansion.
Read more →-UNH
Dec 12, 2022Document Kristen Gil Joins UnitedHealth Group Board of Directors MINNETONKA, Minn . (Dec.12, 2022) - UnitedHealth Group (NYSE UNH) announced Kristen Gil of Alphabet Inc. (NASDAQ GOOG) has been appointed to its Board of D
Kristen Gil Joins UnitedHealth Group Board of Directors MINNETONKA, Minn. (Dec.12, 2022) - UnitedHealth Group (NYSE UNH) announced Kristen Gil of Alphabet Inc. (NASDAQ GOOG) has been appointed to its Board of Directors, effective immediately. Gil currently serves as vice presid
Read more →-UNH
Oct 14, 2022Document UnitedHealth Group Reports Third Quarter 2022 Results Revenues of $80.9 Billion Grew 12% Year-Over-Year, with Diversified Growth across Optum and UnitedHealthcare Earnings from Operations were $7.5 Billion Cash
UnitedHealth Group Reports Third Quarter 2022 Results Revenues of $80.9 Billion Grew 12% Year-Over-Year, with Diversified Growth across Optum and UnitedHealthcare Earnings from Operations were $7.5 Billion Cash Flows from Operations were $18.5 Billion Adjusted Cash Flows from
Read more →-UNH
Oct 3, 2022Optum and Change Healthcare Complete Combination
Optum and Change Healthcare Complete Combination EDEN PRAIRIE, Minn., Oct. 3, 2022: Optum, a diversified health services company, announced it has completed its combination with Change Healthcare. The combined businesses share a vision for achieving a simpler, more intelligent
Read more →-UNH
Jul 15, 2022▲ +5.4%on this news
Document UnitedHealth Group Reports Second Quarter 2022 Results Revenues of $80.3 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Earnings from Operations were $7.1 Billion, G
UnitedHealth Group Reports Second Quarter 2022 Results Revenues of $80.3 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Earnings from Operations were $7.1 Billion, Growth of 19% Year-Over-Year Cash Flows from Operations were $6.9 B
Read more →-UNH
Apr 14, 2022Document UnitedHealth Group Reports First Quarter 2022 Results Revenues of $80.1 Billion Grew $10 Billion or 14% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Earnings from Operations were $
UnitedHealth Group Reports First Quarter 2022 Results Revenues of $80.1 Billion Grew $10 Billion or 14% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Earnings from Operations were $7 Billion Cash Flows from Operations were $5.3 Billion Earnings w
Read more →-UNH
Mar 29, 2022Draft as of March 28, 7 PM CT Optum and LHC Group to Combine, Advancing Abilities to Extend Value-Based Care into Patients Homes EDEN PRAIRIE, Minn. and LAFAYETTE, La. (
Draft as of March 28, 7 PM CT Optum and LHC Group to Combine, Advancing Abilities to Extend Value-Based Care into Patients Homes EDEN PRAIRIE, Minn. and LAFAYETTE, La. (March 29, 2022) Optum, a diversified health services company, and LHC Group (NASDAQ: LHCG), a national patie
Read more →-UNH
Jan 19, 2022Document N E W S R E L E A S E (For Immediate Release) UNITEDHEALTH GROUP REPORTS 2021 RESULTS Revenues of $287.6 Billion Grew 12% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Cash Flows fr
(For Immediate Release) UNITEDHEALTH GROUP REPORTS 2021 RESULTS Revenues of $287.6 Billion Grew 12% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare Cash Flows from Operations were $22.3 Billion or 1.3x Net Income Full Year and Fourth Quarter Net Ea
Read more →-UNH
Oct 14, 2021Document N E W S R E L E A S E (For Immediate Release) UNITEDHEALTH GROUP REPORTS THIRD QUARTER 2021 PERFORMANCE Revenues Increased 11% to $72.3 Billion, with Strong and Diversified Growth across Optum and UnitedHealthca
(For Immediate Release) UNITEDHEALTH GROUP REPORTS THIRD QUARTER 2021 PERFORMANCE Revenues Increased 11% to $72.3 Billion, with Strong and Diversified Growth across Optum and UnitedHealthcare Earnings from Operations $5.7 Billion Cash Flows from Operations $7.6 Billion or 1.8
Read more →-UNH
Jul 15, 2021Document N E W S R E L E A S E (For Immediate Release) UNITEDHEALTH GROUP REPORTS SECOND QUARTER 2021 RESULTS Revenues of $71.3 Billion Grew 15%, with Well-Diversified Growth at Optum and UnitedHealthcare Earnings from O
(For Immediate Release) UNITEDHEALTH GROUP REPORTS SECOND QUARTER 2021 RESULTS Revenues of $71.3 Billion Grew 15%, with Well-Diversified Growth at Optum and UnitedHealthcare Earnings from Operations were $6.0 Billion Cash Flows from Operations reached $5.5 Billion or 1.3x Net
Read more →-UNH
Apr 15, 2021Document N E W S R E L E A S E (For Immediate Release) UNITEDHEALTH GROUP REPORTS FIRST QUARTER PERFORMANCE Revenues of $70.2 Billion Grew 9%, led by Balanced Growth at Optum and UnitedHealthcare Earnings from Operations
(For Immediate Release) UNITEDHEALTH GROUP REPORTS FIRST QUARTER PERFORMANCE Revenues of $70.2 Billion Grew 9%, led by Balanced Growth at Optum and UnitedHealthcare Earnings from Operations Grew 35% to $6.7 Billion Cash Flows from Operations were $6.0 Billion or 1.2x Net Inco
Read more →-UNH
Jan 20, 2021Document N E W S R E L E A S E (For Immediate Release) UNITEDHEALTH GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS Full Year Revenues of $257.1 Billion Grew $15.0 Billion or 6%, led by 21% at Optum Full Year and
(For Immediate Release) UNITEDHEALTH GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS Full Year Revenues of $257.1 Billion Grew $15.0 Billion or 6%, led by 21% at Optum Full Year and Fourth Quarter Net Earnings Per Share of $16.03 and $2.30 Full Year and Fourth Quarter
Read more →-UNH
Jan 6, 2021OptumInsight and Change Healthcare Combine to Advance a More Modern, Information and Technology-Enabled Health Care Platform Accelerates work to improve outcomes and experiences and lower the cost of health care EDEN PRA
OptumInsight and Change Healthcare Combine to Advance a More Modern, Information and Technology-Enabled Health Care Platform Accelerates work to improve outcomes and experiences and lower the cost of health care EDEN PRAIRIE, Minn. and NASHVILLE, Tenn. (January 6, 2021) Optum,
Read more →-UNH
Oct 14, 2020Document N E W S R E L E A S E (For Immediate Release) UNITEDHEALTH GROUP REPORTS THIRD QUARTER PERFORMANCE Revenues of $65.1 Billion Grew 8%, led by 21% Growth at Optum Net Earnings of $3.30 Per Share and Adjusted Earni
(For Immediate Release) UNITEDHEALTH GROUP REPORTS THIRD QUARTER PERFORMANCE Revenues of $65.1 Billion Grew 8%, led by 21% Growth at Optum Net Earnings of $3.30 Per Share and Adjusted Earnings of $3.51 Per Share Results Reflect Extensive Consumer, Customer, Care Provider and
Read more →Competitive Position
How UNH ranks across every disease it competes inCompetitive Position is a premium feature
See how UNH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial